US Patent 7314856 Adrenomedullin agonists
Patent 7314856 was granted and assigned to Auckland Uniservices Limited on January, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Garth James Smith Cooper0
Ian Reginald Reid0
Jillian Cornish0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+242 characters)
Article
Patent abstract
A method for promoting bone growth in a patient (e.g., a mammal such as a human) said method including the step of administering a therapeutically effective amount of adrenomedullin or an adrenomedullin agonist to said patient.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07314856 Adrenomedullin agonists US Patent 7314856 Adrenomedullin agonists
Infobox
Patent Number
073148560
Patent Number
73148560
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073148560
Date of Patent
January 1, 2008
0Patent Application Number
102288720
Date Filed
August 26, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07314856 Adrenomedullin agonists
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07314856
Date of patent
January 1, 2008
Patent application number
10228872
Date Filed
August 26, 2002
Patent primary examiner
Find more entities like US Patent 7314856 Adrenomedullin agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
